Normocytic Anemias Flashcards

1
Q

How does anemia present? How do we test for anemia? How are the anemias classified?

A
  • anemia presents as hypoxia; weakness, fatigue, dyspnea, pale conjunctiva, headache, light-headedness (can present as angina/claudication in patients with CAD and atherosclerosis)
  • tested for with Hb, hematocrit, and RBC count
  • anemia is a Hb less than 13.5 g/dL in males (less than 12.5 in females)
  • classified based on mean corpuscular volume (MCV): microcytic is less than 80, normocytic is between 80 and 100, macrocytic is greater than 100
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is normocytic anemia? What are the general causes of this type of anemia?

A
  • normocytic anemia is characterized by a normal MCV (80-100)
  • it is caused either by increased peripheral destruction/hemolysis (this can be either intravascular or extravascular hemolysis) or by an underproduction of RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the reticulocyte count? What do reticulocytes look like? What is the normal value? What is the significance of this value?

A
  • the reticulocyte count (RC) is the percent of RBCs that are young/new RBCs that have recently been released by the bone marrow (reticulocytes are slightly larger than normal RBCs and have a bluish cytoplasm because of some residual RNA)
  • normal RC is 1-2%; it will increase to be greater than 3% in the setting of anemia and with a functional BM
  • therefore, in the setting of a normocytic anemia, a value greater than 3% indicates that the issue is due to peripheral destruction (because the BM is functional); a value less than 3% indicates the issue is due to underproduction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do we need to correct the reticulocyte count? How do we do this?

A
  • any anemia will falsely raise the RC, as the ratio of reticulocytes to RBCs will increase since the number of RBCs is lowered in anemia
  • correct RC by multiplying the initial value by hematocrit/45*
  • *45 is the normal hematocrit value
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s happening in extravascular hemolysis? What findings will characterize an anemia due to this mechanism?

A
  • extravascular hemolysis is via the RES (the reticuloendothelial system): macrophages in the spleen, liver, and lymph nodes
  • the RES breaks down RBCs back into their basic constituents (unconjugated bilirubin will increase)
  • findings: anemia, splenomegaly, jaundice, bilirubin gallstones, marrow hyperplasia, corrected RC greater than 3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What’s happening in intravascular hemolysis? What findings will characterize an anemia due to this mechanism?

A
  • intravascular hemolysis is the destruction of RBCs in the
    actual vessels, leading to Hb directly leaking into the blood
  • findings: anemia, hemoglobinemia, hemoglobinuria, decreased free haptoglobin*, hemosiderinuria (this occurs a few days after the onset, renal tubular cells absorb the iron and become hemosiderin-laden; when they slough off, hemosiderinuria will result)
  • *haptoglobin is a scavenger molecule that rapidly binds to free Hb in order to save it (it really only saves a very small amount)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the major causes of predominantly extravascular hemolysis resulting in normocytic anemia?

A
  • hereditary spherocytosis: increased RES (reticuloendothelial system) clearance of small spherocytes
  • sickle cell anemia: cycles of sickling and de-sickling damage RBCs, leading to increased RES clearance
  • hemoglobin C: abnormality increases RES clearance
  • immune hemolytic anemia (IgG-mediated; IgM-mediated is mainly via intravascular hemolysis): RES clearance of IgG bound RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the major causes of predominantly intravascular hemolysis resulting in normocytic anemia?

A
  • paroxysmal nocturnal hemoglobinuria: complement-mediated damage to RBCs, platelets, monocytes, granulocytes
  • G6PD deficiency: damage via oxidative stress
  • immune hemolytic anemia (IgM-mediated; IgG-mediated is actually mainly via extravascular hemolysis)
  • microangiopathic hemolytic anemia: microthrombi shear RBCs as they pass through vasculature
  • malaria: life cycle of organism ruptures RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the major causes of normocytic anemia via underproduction?

A
  • renal failure: no EPO
  • parvovirus B19 infection: halts erythropoiesis by infecting erythroid progenitor cells
  • aplastic anemia: damage to hematopoietic stem cells
  • myeloproliferative processes: BM replaced with nonfunctional tissue (i.e. metastatic cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is hereditary spherocytosis? What’s the pathophysiology driving this disorder? What is the key finding on blood smear?

A
  • (anemia mainly due to extravascular hemolysis)
  • hereditary spherocytosis is an inherited defect of the RBC’s cytoskeleton-membrane tethering proteins such as spectrin, ankyrin, and band 3.1
  • the resulting instability yields blebbing of the membrane; the blebs are removed by the spleen; this results in the loss of the normal RBC’s bi-concave shape, resulting in spherocytes (this is the key finding on blood smear)
  • eventually, the RBCs will shrink enough to trigger their complete elimination by the spleen (this causes the anemia; the spherocytes themselves are not the issue!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What findings are associated with hereditary spherocytosis?

A
  • normocytic anemia
  • spherocytes with a loss of the normal central pallor (because the bi-concave shape is lost)
  • increased RDW (RBC distribution width; older cells are smaller because they have lost more membrane)
  • increased MCHC (mean corpuscular Hb concentration)
  • splenomegaly, jaundice, bilirubin gallstones (because it is mainly extravascular hemolysis)
  • increased risk of crisis with parvovirus B19 infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do we diagnose hereditary spherocytosis? How do we treat it?

A
  • Dx with an osmotic fragility test: spherocytes have increased fragility in hypotonic solution compared to normal RBCs
  • treat with splenectomy (note that this will resolve the anemia, but not the spherocytes because the liver and lymph nodes will still remove the membrane blebs); splenectomies result in the presence of Howell-Jolly bodies on blood smear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a Howell-Jolly body?

A
  • Howell-Jolly bodies are seen on blood smear in patients with a splenectomy or a non-functional spleen
  • these are RBCs with some nuclear fragments still remaining; usually, the spleen removes these fragments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is sickle cell anemia? What mutation is involved and what results? What’s the pathophysiology of this anemia? What precipitates the pathophysiology?

A
  • (anemia mainly due to extravascular hemolysis)
  • sickle cell anemia is an autosomal recessive mutation in Hb’s beta chain; the normal glutamic acid (which is hydrophilic) is replaced by valine (which is hydrophobic)
  • the disease requires 2 abnormal genes, which results in more than 90% of RBCs having the abnormal Hb (HbS)
  • HbS has a propensity to polymerize*, resulting in the RBC to develop a needle-like shape (these are the sickle cells)
  • the constant cycling of sickling and de-sickling damages the RBC’s membrane, and the spleen then eliminates these cells
  • *HbS polymerizes when it is deoxygenated; thus risk for a precipitating event increases with hypoxemia, dehydration, and acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What findings are associated with sickle cell disease? When do these findings typically present? Why?

A
  • normocytic anemia
  • presence of sickle cells
  • splenomegaly, jaundice, bilirubin gallstones (because it is mainly extravascular hemolysis)
  • decreased free haptoglobin, hemoglobinemia, hemoglobinuria presence of target cells (because occasionally, the RBCs lyse intravascularly as well)
  • massive erythroid hyperplasia may occur as well (hematopoiesis in skull/”crew cut” and facial bones/chipmunk facies, extra medullary hematopoiesis)
  • increased risk of crisis with parvovirus B19 infection
  • symptoms develop at around 6 months of age because HbF is protective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Occasionally in sickle cell disease, the RBCs get stuck in the sickle form (irreversible sickling); what are some of the major complications of irreversible sickling?

A
  • this can cause vaso-occlusion, leading to ischemia and infarction
  • dactylitis: swollen hands and feet due to occlusive infarcts of these bones; dactylitis is a common presenting sign of sickle cell disease (in 6 mo infants)
  • autosplenectomy: infarction and loss of the spleen; patient is essentially asplenic (infection with encapsulated bugs, Salmonella osteomyelitis, Howell-Jolly bodies); this is the MCC of death in children
  • acute chest syndrome: occlusion of pulmonary microcirculation leading to chest pain, SOB, lung infiltrates; often precipitated by pneumonia; this is the MCC of death in adults
  • pain crisis: occlusion of any tissue
  • renal papillary necrosis: hematuria and proteinuria
17
Q

What is sickle cell trait? What percent of RBCs have HbS in these patients? Do these patients experience sickling?

A
  • sickle cell trait is when a patient has only 1 mutated beta chain gene; less than 50% of RBCs will have HbS (vs. more than 90% in sickle cell disease); RBCs do NOT have 50% HbA and HbS because the functional beta chain gene is slightly more efficient at being transcribed/translated
  • sickling requires at least 50% HbS, so these patients are essentially asymptomatic; HOWEVER, the major exception is in the renal medulla because this area is extremely hypoxic, so these patients will have microscopic hematuria and eventual mild renal failure
18
Q

How do we screen for sickle cell disease and sickle cell trait?

A
  • both the disease and the trait form will be positive with the metabisulfate screen (metabisulfate causes cells with any amount of HbS to sickle)
  • note that on blood smear, sickle cells and target cells are only seen in the disease form
19
Q

What is hemoglobin C? What amino acid change results in this disease? What finding do we see on blood smear?

A
  • (anemia mainly due to extravascular hemolysis)
  • hemoglobin C is due to an autosomal mutation in the beta chain; glutamic acid is replaced by lysine (“HbC has lyCne”)
  • it is less common that sickle cell disease
  • patients have a mild anemia
  • presence of HbC crystals on blood smear (these are rod shaped crystals that are floating with the RBCs; some are able to be seen within the RBCs as well)
20
Q

What is paroxysmal nocturnal hemoglobinuria (PNH)? What’s the pathophysiology behind this disorder? Why does this occur at night?

A
  • (anemia mainly due to intravascular hemolysis)
  • PNH is due to an ACQUIRED defect in myeloid stem cells, resulting in absent GPI (glycosylphosphatidylinositol)
  • GPI is needed to bind DAF and MIRL to the myeloid cell surface; these protect these blood cells against complement
  • when we sleep, our breathing is more shallow and thus we develop a very mild respiratory acidosis (elevated CO2), which triggers complement activation; at night, these patients have lysing of their RBCs, WBCs, and platelets
  • in the morning, the patient’s urine will be dark (hemoglobinuria)
21
Q

What findings are associated with paroxysmal nocturnal hemoglobinuria?

A
  • normocytic anemia (remember due to intravascular hemolysis)
  • nocturanl hemoglobinemia
  • morning hemoglobinuria and hemosiderinuria a few days later
  • this disorder affects neutrophils and platelets as well, so we actually get a PANcytopenia
  • (classic triad is Coombs negative hemolytic anemia, pancytopenia, and venous thrombosis)
22
Q

How do we screen for paroxysmal nocturnal hemoglobinuria? How do we confirm the diagnosis?

A
  • screen for PNH with a sucrose test
  • confirm with an acidified serum test (the acid activates complement) OR with flow cytometry to detect the lack of DAF on the RBCs (CD55)
23
Q

What is the most common cause of death in patients with paroxysmal nocturnal hemoglobinuria? What are two potential complications that may develop in patients?

A
  • MCC of death is thrombosis (especially of the hepatic, portal, and cerebral veins): the lysed platelets release their cytoplasmic contents and result in thrombosis
  • patients may develop iron deficiency anemia (large loss of iron in the hemoglobinuria)
  • 10% of patients develop AML (PNH is due to a defect with the myeloid stem cells, so other defects may also develop, potentially leading to AML)
24
Q

What is G6PD deficiency? What is the pathophysiology that drives this anemia?

A
  • (anemia mainly due to intravascular hemolysis)
  • X-linked recessive disorder leading to a lowered half-life of G6PD in RBCs; this makes these cells susceptible to oxidative stress
  • normally, glutathione gets oxidized by the reactive oxygen species (protecting the cell, itself), the oxidized glutathione must then be reduced back by NADPH in order to continue this function; NADPH is generated by G6PD via glycolysis, so a G6PD deficiency results in a failure to regenerate reduced glutathione
  • oxidative stress can be triggered by infection, drugs (sulfa drugs, antimalarials), fava beans
25
Q

What are the two variants of G6PD deficiency? Are the resulting anemias severe or mild? Why?

A
  • African variant: mildly decreases the half-life of G6PD, leading to a mild anemia (only the older RBCs will have a G6PD deficiency and a susceptibility to oxidative stress)
  • Mediterranean variant: severely decreases the half-life, leading to a severe anemia (younger cells will also have the G6PD deficiency)
26
Q

What findings are associated with G6PD deficiency anemia?

A
  • normocytic anemia
  • hemaglobinemia, hemaglobinuria, lowered free haptoglobin, hemosiderinuria (it’s mainly an intravascular hemolytic disorder)
  • Heinz bodies (precipitates of Hb in RBCs; precipitation is a result of the oxidative stress)
  • bite cells (RBCs with “bites” removed by the spleen; these “bites” remove the Heinz bodies)
  • patients also commonly present with back pain
27
Q

What is immune hemolytic anemia? What are the two types and what is the pathophysiology of each? What is each associated with?

A
  • immune hemolytic anemia is the Ab mediated destruction of RBCS; 2 types: IgG/warm-agglutinin and IgM/cold-agglutinin
  • IgG-mediated: mainly extravascular hemolysis; splenic macrophages eat away at IgG-bound RBCs, forming spherocytes, eventually consuming the entire cell (same idea as hereditary spherocytosis); associated with SLE, CLL, and some drugs
  • IgM-mediated: mainly intravascular hemolysis; IgM-bound RBCs gets fixed with complement, resulting in cell lysis; associated with Mycoplasma pneumoniae and infectious mononucleosis
28
Q

What is the Coombs test?

A
  • the Coombs test is a specific test that tests for antibody-mediated hemolysis
  • the direct Coombs test looks for Ab-coated RBCs; anti-Ab antibodies are mixed with the patient’s RBCs, and the mixture will agglutinate if the RBCs are already coated with an Ab (it is used to diagnose immune hemolytic anemia)
  • the indirect Coombs test looks for the presence of the Ab in the serum; anti-Ab antibodies are mixed with TEST RBCs and the patient’s serum, and the mixture will agglutinate if the Abs in question are present (it is mainly used to diagnose Rhesus factor hemolysis)
29
Q

What is microangiopathic hemolytic anemia? What’s the pathophysiology behind this disorder? What classic cell finding is seen? Which conditions is it seen in?

A
  • (this is an extrinsic hemolytic anemia)
  • this disorder is characterized by the formation of microthrombi that partially occlude the vasculature; RBCs get sheared as they pass through the circulation
  • sheared shape: schistocytes AKA “helmet cells”
  • microangiopathic hemolytic anemia is seen in TPP (thrombotic thrombocytic purpura), HUS (hemolytic uremic syndrome), DIC, malignant HTN
  • (macroangiopathic anemia occurs due to prosthetic heart valves and aortic stenosis)
30
Q

What is malaria? What vector carries the bug? What causes the hemolysis in this disease and how do patients present?

A
  • (this is an extrinsic hemolytic anemia)
  • malaria is an infection of the RBCs and liver with Plasmodium spp. (P. falciparum, P. vivax, P. ovale)
  • transmitted by the female Anopheles mosquito
  • the organism’s life cycle results in the rupturing of the RBC (causing the anemia)
  • patients present with intravascular hemolysis and cyclical fever
  • (note that the spleen will also eliminate some of the infected RBCs, so extravascular hemolysis also occurs)
31
Q

What characterizes anemia via underproduction? What can cause this?

A
  • underproduction is characterized by a corrected RC less than 3%
  • can result from anything that causes microcytic or macrocytic anemia, renal failure, damage to the bone marrow stem cells
  • parvovirus B19: infects erythroblasts; usually self-limiting, only an issue in patients with underlying marrow stress
  • aplastic anemia: damage to hematopoietic stem cells, leading to pancytopenia; biopsy reveals an empty BM (only fat is seen); can be due to drugs, chemicals, viral infections, autoimmune damage
  • myelophthisic process: replacement of BM with non-functional tissue such as cancer, fibrosis, etc. (main example is widespread metastatic cancer)
32
Q

Compare serum electrophoresis in a patient with sickle cell anemia vs. a patient with sickle cell trait.

A
  • (normal: HbA 97%, HbS 0%, HbA2 2%, HbF 1%)
  • disease: HbA 0%, HbS 90%, HbA2 2%, HbF 8%
  • trait: HbA 52%, HbS 45%, HbA2 2%, HbF 1%